{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Modafinil+Placebo&page=2", "query": { "intervention": "Modafinil Placebo", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Modafinil+Placebo&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-01T19:39:19.777Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00118378", "title": "Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HIV Infections", "Fatigue" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 115, "start_date": "2004-12", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2017-05-10", "last_synced_at": "2026-09-01T19:39:19.777Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00118378" }, { "nct_id": "NCT00555347", "title": "Use of Armodafinil for Fatigue in Sarcoidosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Sarcoidosis", "Fatigue", "Sleepiness" ], "interventions": [ { "name": "Armodafinil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2007-10", "completion_date": "2011-08", "has_results": false, "last_update_posted_date": "2015-05-27", "last_synced_at": "2026-09-01T19:39:19.777Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00555347" }, { "nct_id": "NCT01781468", "title": "Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fatigue" ], "interventions": [ { "name": "armodafinil 150 mg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "armodafinil 250 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 328, "start_date": "2013-06-21", "completion_date": "2019-12-15", "has_results": true, "last_update_posted_date": "2025-01-27", "last_synced_at": "2026-09-01T19:39:19.777Z", "location_count": 365, "location_summary": "Anchorage, Alaska • Fairbanks, Alaska • Phoenix, Arizona + 254 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01781468" }, { "nct_id": "NCT00223691", "title": "Treatment of Orthostatic Hypotension in Autonomic Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autonomic Failure", "Orthostatic Hypotension" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Acarbose", "type": "DRUG" }, { "name": "Pyridostigmine Bromide", "type": "DRUG" }, { "name": "Yohimbine", "type": "DRUG" }, { "name": "Midodrine HCl", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "Modafinil", "type": "DRUG" }, { "name": "Octreotide", "type": "DRUG" }, { "name": "water intake", "type": "OTHER" }, { "name": "Diphenhydramine Hydrochloride", "type": "DRUG" }, { "name": "Ranitidine HCL", "type": "DRUG" }, { "name": "Tranylcypromine", "type": "DRUG" }, { "name": "Ergotamine/ Caffeine", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Pseudoephedrine", "type": "DRUG" }, { "name": "Methylphenidate", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Oxymetazoline 0.05% nasal solution", "type": "DRUG" }, { "name": "Bovril", "type": "DIETARY_SUPPLEMENT" }, { "name": "Acetazolamide", "type": "DRUG" }, { "name": "Rivastigmine tartrate", "type": "DRUG" }, { "name": "Carbidopa/levodopa", "type": "DRUG" }, { "name": "Inflatable abdominal binder", "type": "DEVICE" }, { "name": "inflatable abdominal binder (sham)", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DIETARY_SUPPLEMENT", "DEVICE" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 389, "start_date": "2002-03", "completion_date": "2017-01", "has_results": false, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-09-01T19:39:19.777Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00223691" }, { "nct_id": "NCT01085903", "title": "Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Spatial Neglect", "Dysphagia" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Baseline", "type": "BEHAVIORAL" }, { "name": "CPS", "type": "BEHAVIORAL" }, { "name": "Post CPS", "type": "BEHAVIORAL" }, { "name": "Follow up", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "19 Years to 85 Years" }, "enrollment_count": 28, "start_date": "2010-03", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2016-10-18", "last_synced_at": "2026-09-01T19:39:19.777Z", "location_count": 2, "location_summary": "Conway, Arkansas • Little Rock, Arkansas", "locations": [ { "city": "Conway", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01085903" }, { "nct_id": "NCT05351541", "title": "Psilocybin Therapy for Chronic Low Back Pain", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Chronic Low-back Pain" ], "interventions": [ { "name": "Psilocybin therapy with Zolpidem and Modafinil", "type": "DRUG" }, { "name": "Psilocybin therapy with Zolpidem", "type": "DRUG" }, { "name": "Psilocybin therapy with Modafinil", "type": "DRUG" }, { "name": "Psilocybin therapy with Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Joshua Woolley, MD, PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "25 Years to 70 Years" }, "enrollment_count": 30, "start_date": "2023-12-01", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-09-01T19:39:19.777Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05351541" }, { "nct_id": "NCT02468856", "title": "Effect of Armodafinil on Simulated Driving", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "armodafinil", "type": "DRUG" }, { "name": "Placebo (for armodafinil)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 12, "start_date": "2017-05-21", "completion_date": "2017-11-30", "has_results": false, "last_update_posted_date": "2018-12-31", "last_synced_at": "2026-09-01T19:39:19.777Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02468856" }, { "nct_id": "NCT00825227", "title": "Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fatigue", "Chemotherapy Side Effects" ], "interventions": [ { "name": "Armodafinil 150 mg/day", "type": "DRUG" }, { "name": "Placebo,", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cephalon", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2008-12", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2017-11-17", "last_synced_at": "2026-09-01T19:39:19.777Z", "location_count": 29, "location_summary": "Muscle Shoals, Alabama • Burbank, California • Fountain Valley, California + 25 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Burbank", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "La Verne", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00825227" }, { "nct_id": "NCT00573417", "title": "A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "modafinil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "North Suffolk Mental Health Association", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2003-09", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2009-08-12", "last_synced_at": "2026-09-01T19:39:19.777Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00573417" }, { "nct_id": "NCT01172145", "title": "Treatment of Apathy in Alzheimer's Disease With Modafinil", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Apathy", "Alzheimer's Disease" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "65 Years to 95 Years" }, "enrollment_count": 22, "start_date": "2005-07", "completion_date": "2007-09", "has_results": true, "last_update_posted_date": "2011-03-04", "last_synced_at": "2026-09-01T19:39:19.777Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT01172145" } ] }